Research progress of antibody-drug conjugates therapy for HER2-low expressing gastric cancer.
Transl Oncol
; 29: 101624, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36652760
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Transl Oncol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
United States